News & Updates
Filter by Specialty:
Show Multimedia Only

Romosozumab improves bone health in osteoporotic women with diabetes
27 Sep 2025
byStephen Padilla
Treatment with romosozumab for 12 months, followed by 24 months of alendronate, results in significant improvements in lumbar spine areal bone mineral density (BMD) and tissue thickness-adjusted trabecular bone score (TBS) algorithm (TBSTT) compared with alendronate alone among postmenopausal women with osteoporosis and type 2 diabetes (T2D), reports a study.
Romosozumab improves bone health in osteoporotic women with diabetes
27 Sep 2025
Oral methylcobalamin eases hand-foot syndrome in breast cancer patients
26 Sep 2025
byStephen Padilla
The use of oral methylcobalamin is effective in lessening the severity of hand-foot syndrome, without any serious safety concerns, among women with HER2 negative early breast cancer who are treated with adjuvant capecitabine, a study has shown.